참고문헌
- Park EH, Min SY, Kim Z, et al. Basic facts of breast cancer in Korea in 2014: the 10-year overall survival progress. J Breast Cancer 2017;20:1-11. https://doi.org/10.4048/jbc.2017.20.1.1
- Jung KW, Won YJ, Oh CM, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat 2017;49:292-305. https://doi.org/10.4143/crt.2017.118
- Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26 Suppl 5:v8-30. https://doi.org/10.1093/annonc/mdv298
- Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: metaanalysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378:1707-16. https://doi.org/10.1016/S0140-6736(11)61629-2
- Sanghani M, Balk E, Cady B, Wazer D. Predicting the risk of local recurrence in patients with breast cancer: an approach to a new computer-based predictive tool. Am J Clin Oncol 2007;30:473-80. https://doi.org/10.1097/COC.0b013e31805c13d9
- Sanghani M, Truong PT, Raad RA, et al. Validation of a webbased predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol 2010;28:718-22. https://doi.org/10.1200/JCO.2009.22.6662
- Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med 2015;373:503-10. https://doi.org/10.1056/NEJMoa1504473
- Chang JS, Lee J, Chun M, et al. Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: a multi-institutional validation study of the ESTRO consensus guideline on clinical target volume. Radiother Oncol 2018;126:139-47. https://doi.org/10.1016/j.radonc.2017.09.031
- Chang JS, Byun HK, Kim JW, et al. Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: validation of the ESTRO consensus guideline on target volume. Radiother Oncol 2017;122:24-9.
- Chang JS, Park W, Kim YB, et al. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up. Int J Radiat Oncol Biol Phys 2013;86:867-72. https://doi.org/10.1016/j.ijrobp.2013.02.037
- Kindts I, Laenen A, Peeters S, et al. Validation of the web-based IBTR! 2.0 nomogram to predict for ipsilateral breast tumor recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 2016;95:1477-84. https://doi.org/10.1016/j.ijrobp.2016.03.036
- Jung SP, Hur SM, Lee SK, et al. Validation of a Web-based tool to predict the ipsilateral breast tumor recurrence (IBTR! 2.0) after breast-conserving therapy for Korean patients. J Breast Cancer 2013;16:97-103. https://doi.org/10.4048/jbc.2013.16.1.97
- Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 2008;26:1364-70. https://doi.org/10.1200/JCO.2007.12.9791
- Mohammed RA, Martin SG, Gill MS, Green AR, Paish EC, Ellis IO. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol 2007;31:1825-33. https://doi.org/10.1097/PAS.0b013e31806841f6
- American College of Radiology; American College of Surgeons; College of American Pathologists; Society of Surgical Oncology; Winchester DP, Cox JD. Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J Clin 1998;48:83-107. https://doi.org/10.3322/canjclin.48.2.83
- Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000;18:1668-75. https://doi.org/10.1200/JCO.2000.18.8.1668
- Van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M. Relationship between margin width and recurrence of ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery for 30 years. Ann Surg 2015;262:623-31.
- Sartor CI, Peterson BL, Woolf S, et al. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. J Clin Oncol 2005;23:30-40. https://doi.org/10.1200/JCO.2005.12.044
- Ferretti G, Papaldo P, Fabi A, Carlini P, Felici A, Cognetti F. Adjuvant trastuzumab with docetaxel or vinorelbine for HER-2-positive breast cancer. Oncologist 2006;11:853-4. https://doi.org/10.1634/theoncologist.11-7-853
- Fisher B, Jeong JH, Bryant J, et al. Treatment of lymph-nodenegative, oestrogen-receptor-positive breast cancer: longterm findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Lancet 2004;364:858-68. https://doi.org/10.1016/S0140-6736(04)16981-X
- Frechette D, Paquet L, Verma S, et al. The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study. Breast Cancer Res Treat 2013;141:111-7. https://doi.org/10.1007/s10549-013-2659-y
피인용 문헌
- Hypofractionated Radiotherapy Dose Scheme and Application of New Techniques Are Associated to a Lower Incidence of Radiation Pneumonitis in Breast Cancer Patients vol.10, pp.None, 2018, https://doi.org/10.3389/fonc.2020.00124
- The Acute and Late Toxicities of MRI-Guided External Beam Partial Breast Irradiation Delivered Using a Once-Per-Day Regimen vol.11, pp.None, 2018, https://doi.org/10.3389/fonc.2021.649301